Biobanks: Importance, Implications and Opportunities for Genetic Counselors.

Personalized medicine.

Bioethics in Iceland.

Implementing genotype-guided antithrombotic therapy.

Consent to 'personal' genomics and privacy. Direct-to-consumer genetic tests and population genome research challenge traditional notions of privacy and consent.

Confidentiality and sharing genetic information with relatives.

Patenting of human genetic material v. bioethics: revisiting the case of John Moore v. Regents of the University of California.

Anonymization of electronic medical records for validating genome-wide association studies.

Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: the problem of misattributed equivalence.

Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.

Personal genome sequencing: current approaches and challenges.

GINA and preemployment criminal background checks.

Translational bioinformatics and healthcare informatics: computational and ethical challenges.

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.

Return of "accurate" and "actionable" results: yes!

Direct-to-consumer genomics and research ethics: should a more robust informed consent process be included?

Challenges in the use of direct-to-consumer personal genome testing in children.

Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?

International web-based survey of informed consent procedures in genetic epidemiological studies: towards the establishment of a research coordinator accreditation system.

Nursing advocacy in a postgenomic age.

How will GINA influence participation in pharmacogenomics research and clinical testing?

Comparison of participant information and informed consent forms of five European studies in genetic isolated populations.